# Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dose-comparison-study-of-the-combination-of-ezetimibe-and-simvastatin-vytorin/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christie M. Ballantyne,Nicola Abate,Žhong Yuan,Thomas King,Joanne Palmisano |
| Citations | 240 |
| DOI | 10.1016/j.ahj.2004.11.023 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2062693500 |
| PMID | 15864235 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Žhong Yuan](https://scholariq.org/researchers/zhong-yuan/)

## Paper journal

- [American Heart Journal](https://scholariq.org/journals/american-heart-journal/)

## Paper primary topic

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Paper topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Cancer, Lipids, and Metabolism](https://scholariq.org/topics/cancer-lipids-and-metabolism/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.